Adherence and Healthcare Utilization Following Initiation of Sacubitril/Valsartan Among Veterans With Heart Failure and Reduced Ejection Fraction

被引：0
|
作者：
Mohanty, April
Levitan, Emily B.
Dodson, John A.
He, Tao
Russo, Patricia A.
Bress, Adam P.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; adult;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13540
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context
    D'Angiolella, Lucia S.
    Cortesi, Paolo A.
    Pitotti, Claudia
    Ritrovato, Daniela
    Mantovani, Lorenzo G.
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1551 - 1553
  • [42] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION IN SWEDEN
    Costa-Scharplatz, M.
    Lang, A.
    McMurray, J. J.
    Woodcock, F.
    Haroun, R.
    Johansson, D.
    Lund, L. H.
    VALUE IN HEALTH, 2016, 19 (07) : A650 - A651
  • [43] The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Martens, Pieter
    Belien, Hanne
    Dupont, Matthias
    Vandervoort, Pieter
    Mullens, Wilfried
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (04)
  • [44] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [45] Electrocardiographic predictors of response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Shpigelman, Jonathan
    Blaine, Ciara
    Nugent, Carol-Ann
    Kiernan, Louise
    Cahir, Caitriona
    Mac Curtain, Benjamin
    Bachari, Amir
    Irfan, Wadeed
    O'Boyle, Patrick
    O'Neill, James
    Daly, Michael
    JOURNAL OF ELECTROCARDIOLOGY, 2024, 84 : 104 - 108
  • [46] DIASTOLIC FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED BY SACUBITRIL/VALSARTAN
    Lamaida, N.
    Cerciello, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [47] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Barman, Hasan Ali
    Tanyolac, Selim
    Dogan, Omer
    Bal, Erdem
    Atici, Adem
    Ozyildirim, Serhan
    Yigit, Zerrin
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 533 - 540
  • [48] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [49] The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Martens, P. Pieter
    Belien, H.
    Dupont, M.
    Mullens, W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 256 - 256
  • [50] The cost-effectiveness of sacubitril/valsartan in chronic heart failure with reduced ejection fraction
    Mcmurray, J. J. V.
    Cowie, M. R.
    Briggs, A.
    Taylor, M.
    Hancock, E.
    Trueman, D. David
    Haroun, R.
    Deschaseaux, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 276 - 276
12345